|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.75 HKD | +1.41% |
|
-1.20% | -14.56% |
| 25/04 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
| 10/04 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
Simcere Pharmaceutical Group announced the appointment of Dr. Zang Jingwu as Chief Scientific Officer of the Company, effective October 8, 2013.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.56% | 1.88B | |
| +21.63% | 44.11B | |
| +23.03% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
SIMCERE PHARMACEUTICAL GROUP LIMITED 
